drugset / Trial / NCT00883727

Ex Vivo Cultured Bone Marrow Derived Allogenic MSCs in AMI

NCT00883727

Phase 1/2 Completed 20 enrolled Stempeutics Research Pvt Ltd
RandomizedParallel-groupTriple-blindTreatment

Summary

This clinical trial aims to find out the safety and efficacy of adult mesenchymal stem cells in patients with myocardial infarction.

Timeline

Start
2009-04
Primary completion
2010-05
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Stempeucel® Cell therapy Intravenous

Indications